Looking for buying opportunity in this stock. as it is gud reversal from down side A very gud risk reward trade. SL and First target as shown in the figure.
There is a breakout of The Rising Three Pattern on weekly TF. Potential Target would be 2,213/- in next two months (By Jan 24). Volume increased with prices increased (From May to Aug) but with price correction there is no substantial volume which signifies Gland Pharma is in uptrend. Note: It is not at all the buying and selling recommendation and this stock is...
Twitter : vikasparmar055 GLAND PHARMA !! Breakout about to come !! #glandpharma #GLAND 1) Trend change with very good volume 2) Near previous Resistance, about to break with good volume 3) Perfect entry for swing trading
GLAND PHARMA !! Breakout about to come !! - Trend change with very good volume - near previous Resistance, about to break with good volume - Perfect entry for swing trading
After given a temporary breakdown of 1680 level NSE:GLAND again sustained above level of 1680, which is best entry level for positional buyer with stop loss of 1640 (-40 risk only). My expected upside target would be 1720 (+40) & 1754 (+74). This could be low risk and high reward idea. Note: This is my personal analysis, only to learn stock market behavior. Thanks.
This is my personal view that Gland Pharma Ltd ha very potential uptrend for coming future. I tried to figure it out with the Fib Retracement with Anchored volume profile. As I have noticed it retraced exactly from -1.618 (905.85). Target 1.618, which is 3190.45 Let me know if you have different views.. Thanks for viewing.
the stock broke the trend line and ready to push for 0.618 fib levels ..best for long term investment. 50 MA golden cross coming soon..
In chart as you see after long down trend on weekly chart stock has gave breakout and retest one can go with stop loss below previous candle. Do deep analysis before enter or take advise from your financial advisor . Always follow stop loss .
it is consolidated in monthly TF. keep watching. Earlier it is going continous down but now it is consolidation in same price range. thats why it is in my radar. kindly watch
Short term view : Gland Pharma #GLAND 861 low created on 22nd May.... It was a demand zone.. Now i believe the area 1710 as resistance.. if break and sustain above 1710 atleast a day candle it will move more upside.... Charts for Educational purposes only. Strictly follow Risk Reward and Stop Loss if you consider the level Thanks, V Trade Point
I'm not saying that Gland Pharma is good, but if you keep portion of the stock, you could see a significant return with a strict stop loss of 892 to 875 (Big Range). I believe that if it crosses 952-955, it may reach 980, 1060, or 1200. This is purely for educational purposes; it is not a recommendation, and neither am I a registered advisor with SEBI. Don't...
Gland Pharma 30% upside potential. Already taken support from lowest level. This is for the study purpose only.
Gland Pharma has been in a long term bearish trend, which has it's bottom around 856 and has made a morning star pattern in the weekly time frame along with a bullish RSI divergence. A continuation green candle can act as signal for short term reversal. It can act as a bottom picking candidate with a stop loss around all time low, providing us with a favourable...
formation base at lower levels, debt-free company, extractive PE levels
All details are given on chart. If you like the analyses please do share it with your friends, like and follow me for more such interesting charts. Disc - Am not a SEBI registered. Please do your own analyses before taking position. This post is only for educational purposes and not a trading recommendation
As per my analysis NSE:GLAND is trading at very high demand level. My idea is to take buy entry at 1345 with stop loss of only 1290 (-55 Points Risk). My expected upside target will be 1557 (+212 Points). Note: This is my personal analysis, only for learning.
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We...
Gland pharma is the now the all tme low lever this is the ipo listing price most people think to buy this level, But Don't catch the falling Knife